Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | LSS | P48449 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16013165 | 0.83 | CNR1 (0.44) | CNR1CNR2THRBTHRA | |
| SCHEMBL16013164 | 0.83 | CNR1 (0.44) | CNR1CNR2THRBTHRA | |
| Hydrochloric Acid SCHEMBL9735260 | 0.83 | HRH3 (0.72) | HRH3KDM4EALDH1A1SMN1; SMN2LSS | |
| SCHEMBL30457592 | 0.80 | HRH3 (0.53) | HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL19193902 | 0.80 | HRH3 (0.50) | HRH3KDM4EALDH1A1SMN1; SMN2THRB | |
| SCHEMBL5267965 | 0.79 | CNR1 (0.46) | CNR1CNR2 | |
| SCHEMBL31442767 | 0.77 | CNR2 (0.54) | CNR1CNR2THRBTHRAHTR1A | |
| SCHEMBL2759077 | 0.77 | PLA2G2A (0.55) | — | |
| SCHEMBL12333299 | 0.77 | CNR1 (0.44) | CNR1CNR2 | |
| SCHEMBL11388482 | 0.76 | HRH3 (0.62) | HRH3KDM4EALDH1A1SMN1; SMN2LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4452934-A1 | IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM | Providence Therapeutics Holdings Inc. (CA) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023115221-A1 | IONIZABLE DILSULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |